Hepatitis C virus inhibitors

Hepatitis C virus inhibitors

The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ferreira, Glenn, Mack, Brendan, Domagalski, Nathan R, Hallow, Daniel M, Savage, Scott A, Vemishetti, Purushotham, Qiu, Yuping, Hobson, Lindsay, Rogers, Amanda, Fenster, Michael, Lou, Sha
Format: Patent
Sprache:eng
Schlagworte:
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Ferreira, Glenn
Mack, Brendan
Domagalski, Nathan R
Hallow, Daniel M
Savage, Scott A
Vemishetti, Purushotham
Qiu, Yuping
Hobson, Lindsay
Rogers, Amanda
Fenster, Michael
Lou, Sha
description The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US10494400B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US10494400B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US10494400B23</originalsourceid><addsrcrecordid>eNrjZJDxSC1ILMksySxWcFYoyywqLVbIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhgYmliYmBgZORsbEqAEAo7Qj5Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Hepatitis C virus inhibitors</title><source>esp@cenet</source><creator>Ferreira, Glenn ; Mack, Brendan ; Domagalski, Nathan R ; Hallow, Daniel M ; Savage, Scott A ; Vemishetti, Purushotham ; Qiu, Yuping ; Hobson, Lindsay ; Rogers, Amanda ; Fenster, Michael ; Lou, Sha</creator><creatorcontrib>Ferreira, Glenn ; Mack, Brendan ; Domagalski, Nathan R ; Hallow, Daniel M ; Savage, Scott A ; Vemishetti, Purushotham ; Qiu, Yuping ; Hobson, Lindsay ; Rogers, Amanda ; Fenster, Michael ; Lou, Sha</creatorcontrib><description>The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.</description><language>eng</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191203&amp;DB=EPODOC&amp;CC=US&amp;NR=10494400B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20191203&amp;DB=EPODOC&amp;CC=US&amp;NR=10494400B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Ferreira, Glenn</creatorcontrib><creatorcontrib>Mack, Brendan</creatorcontrib><creatorcontrib>Domagalski, Nathan R</creatorcontrib><creatorcontrib>Hallow, Daniel M</creatorcontrib><creatorcontrib>Savage, Scott A</creatorcontrib><creatorcontrib>Vemishetti, Purushotham</creatorcontrib><creatorcontrib>Qiu, Yuping</creatorcontrib><creatorcontrib>Hobson, Lindsay</creatorcontrib><creatorcontrib>Rogers, Amanda</creatorcontrib><creatorcontrib>Fenster, Michael</creatorcontrib><creatorcontrib>Lou, Sha</creatorcontrib><title>Hepatitis C virus inhibitors</title><description>The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJDxSC1ILMksySxWcFYoyywqLVbIzMvITMosyS8q5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8aHBhgYmliYmBgZORsbEqAEAo7Qj5Q</recordid><startdate>20191203</startdate><enddate>20191203</enddate><creator>Ferreira, Glenn</creator><creator>Mack, Brendan</creator><creator>Domagalski, Nathan R</creator><creator>Hallow, Daniel M</creator><creator>Savage, Scott A</creator><creator>Vemishetti, Purushotham</creator><creator>Qiu, Yuping</creator><creator>Hobson, Lindsay</creator><creator>Rogers, Amanda</creator><creator>Fenster, Michael</creator><creator>Lou, Sha</creator><scope>EVB</scope></search><sort><creationdate>20191203</creationdate><title>Hepatitis C virus inhibitors</title><author>Ferreira, Glenn ; Mack, Brendan ; Domagalski, Nathan R ; Hallow, Daniel M ; Savage, Scott A ; Vemishetti, Purushotham ; Qiu, Yuping ; Hobson, Lindsay ; Rogers, Amanda ; Fenster, Michael ; Lou, Sha</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US10494400B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><toplevel>online_resources</toplevel><creatorcontrib>Ferreira, Glenn</creatorcontrib><creatorcontrib>Mack, Brendan</creatorcontrib><creatorcontrib>Domagalski, Nathan R</creatorcontrib><creatorcontrib>Hallow, Daniel M</creatorcontrib><creatorcontrib>Savage, Scott A</creatorcontrib><creatorcontrib>Vemishetti, Purushotham</creatorcontrib><creatorcontrib>Qiu, Yuping</creatorcontrib><creatorcontrib>Hobson, Lindsay</creatorcontrib><creatorcontrib>Rogers, Amanda</creatorcontrib><creatorcontrib>Fenster, Michael</creatorcontrib><creatorcontrib>Lou, Sha</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Ferreira, Glenn</au><au>Mack, Brendan</au><au>Domagalski, Nathan R</au><au>Hallow, Daniel M</au><au>Savage, Scott A</au><au>Vemishetti, Purushotham</au><au>Qiu, Yuping</au><au>Hobson, Lindsay</au><au>Rogers, Amanda</au><au>Fenster, Michael</au><au>Lou, Sha</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Hepatitis C virus inhibitors</title><date>2019-12-03</date><risdate>2019</risdate><abstract>The present disclosure relates to methods for making asunaprevir, useful treatment of Hepatitis C virus (HCV) infection, and its intermediates.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US10494400B2
source esp@cenet
subjects CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
title Hepatitis C virus inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-08T06%3A17%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Ferreira,%20Glenn&rft.date=2019-12-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS10494400B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true